| (Values in U.S. Thousands) | Sep, 2016 | Jun, 2016 | Mar, 2016 | Dec, 2015 | Sep, 2015 |
| Sales | -9,999,000 | 70 | 0 | 9,800 | 100 |
| Sales Growth | -14,284,181.66% | unch | -100.00% | +9,699.90% | +147.62% |
| Net Income | -9,999,000 | -4,200 | -1,180 | 9,060 | -3,010 |
| Net Income Growth | -237,971.49% | -255.93% | -113.02% | +401.00% | +14.00% |
Bioniche Life Scienc (BNHLF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Telesta Therapeutics Inc. is a biopharmaceutical company. The Company is focused on the development, manufacturing and commercialization of transformative human therapeutics. Its lead product candidate consists of mycobacterial cell wall-nucleic acid complex, a complex biologic immunotherapy/immunomodulator designed for the treatment of non-muscle-invasive bladder cancer in humans which is in clinical trial. Telesta Therapeutics Inc. is headquartered in Pointe-Claire, Canada.
Fiscal Year End Date: 06/30